Accessibility Menu
 

enGene

(NASDAQ) ENGN

Current Price$6.75
Market Cap$456.20M
Since IPO (2022)-31%
5 YearN/A
1 Year+56%
1 Month-32%

enGene Financials at a Glance

Market Cap

$456.20M

Revenue (TTM)

$0.00

Net Income (TTM)

$122.44M

EPS (TTM)

$-2.25

P/E Ratio

-3.02

Dividend

$0.00

Beta (Volatility)

0.27 (Low)

Price

$6.75

Volume

5,878

Open

$6.83

Previous Close

$6.75

Daily Range

$6.65 - $6.99

52-Week Range

$2.65 - $12.25

ENGN News

ENGN: Motley Fool Moneyball Superscore

56

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About enGene

Industry

Biotechnology

Employees

82

CEO

Ronald Harold Wilfred Cooper

Headquarters

Saint-Laurent, H4S 1Z9, CA

ENGN Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-46%

Return on Capital

-41%

Return on Assets

-36%

Earnings Yield

-33.11%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$456.20M

Shares Outstanding

66.99M

Volume

5.88K

Short Interest

0.00%

Avg. Volume

422.65K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$123.17M

EBITDA

$113.80M

Operating Cash Flow

$99.24M

Capital Expenditure

$1.49M

Free Cash Flow

$100.72M

Cash & ST Invst.

$193.81M

Total Debt

$31.80M

enGene Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$189.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$456.20M

N/A

Market Cap/Employee

$8.15M

N/A

Employees

56

N/A

Net Income

$29.75M

-20.9%

EBITDA

$28.83M

-21.4%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$242.48M

+28.5%

Accounts Receivable

$1.20M

+178.4%

Inventory

$0.00

N/A

Long Term Debt

$30.96M

+34.4%

Short Term Debt

$2.51M

+19.0%

Return on Assets

-36.32%

N/A

Return on Invested Capital

-40.88%

N/A

Free Cash Flow

$29.06M

-11.8%

Operating Cash Flow

$28.90M

-12.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DBVTDBV Technologies S.A.
$20.50-1.87%
LRMRLarimar Therapeutics, Inc.
$4.68+4.00%
CLLSCellectis S.A.
$3.38+6.62%
AMRNAmarin Corporation plc
$14.64+1.24%

Trending Stocks

Symbol / CompanyPricePrice Chg
CYCNCyclerion Therapeutics
$6.38+3.12%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.23+0.04%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.45-0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.77+0.05%

Questions About ENGN

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.